Long-term complications of COVID-19

AD Desai, M Lavelle… - American Journal of …, 2022 - journals.physiology.org
SARS-CoV-2 has rapidly spread across the globe and infected hundreds of millions of
people worldwide. As our experience with this virus continues to grow, our understanding of …

[HTML][HTML] Post-acute COVID-19 syndrome

A Nalbandian, K Sehgal, A Gupta, MV Madhavan… - Nature medicine, 2021 - nature.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the pathogen
responsible for the coronavirus disease 2019 (COVID-19) pandemic, which has resulted in …

SARS‐CoV‐2 variants and vulnerability at the global level

VP Chavda, AB Patel… - Journal of medical …, 2022 - Wiley Online Library
Numerous variants of the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)
pandemic have evolved. Viral variants may evolve with harmful susceptibility to the immunity …

Gastrointestinal manifestations in COVID-19

JC Kariyawasam, U Jayarajah, R Riza… - Transactions of The …, 2021 - academic.oup.com
Abstract Coronavirus disease 2019 (COVID-19), a respiratory viral infection, has affected
more than 78 million individuals worldwide as of the end of December 2020. Previous …

[HTML][HTML] Skeletal muscle damage in COVID-19: a call for action

AM Ali, H Kunugi - Medicina, 2021 - mdpi.com
Both laboratory investigations and body composition quantification measures (eg, computed
tomography, CT) portray muscle loss in symptomatic Coronavirus disease 2019 (COVID-19) …

[HTML][HTML] Therapeutics for COVID-19 and post COVID-19 complications: An update

D Basu, VP Chavda, AA Mehta - Current Research in Pharmacology and …, 2022 - Elsevier
Since its inception in late December 2020 in China, novel coronavirus has affected the
global socio-economic aspect. Currently, the world is seeking safe and effective treatment …

[HTML][HTML] Diagnostic, prognostic, and therapeutic roles of gut microbiota in COVID-19: a comprehensive systematic review

Y Farsi, A Tahvildari, M Arbabi, F Vazife… - Frontiers in cellular …, 2022 - frontiersin.org
Introduction The Coronavirus Disease 2019 (COVID-19) pandemic caused by Severe Acute
Respiratory Coronavirus 2 (SARS-CoV-2) emerged in late December 2019. Considering the …

[HTML][HTML] COVID-19 as a trigger of irritable bowel syndrome: A review of potential mechanisms

CR Settanni, G Ianiro, FR Ponziani… - World Journal of …, 2021 - ncbi.nlm.nih.gov
In December 2019 a novel coronavirus disease 2019 (COVID-19), caused by the severe
acute respiratory syndrome coronavirus-2 (SARS-CoV-2), started spreading from Wuhan city …

Postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection: a state-of-the-art review

DH Jiang, DJ Roy, BJ Gu, LC Hassett… - Basic to Translational …, 2021 - jacc.org
The vast majority of patients (> 99%) with severe acute respiratory syndrome coronavirus 2
survive immediate infection but remain at risk for persistent and/or delayed multisystem. This …

A new capacity of gut microbiota: Fermentation of engineered inorganic carbon nanomaterials into endogenous organic metabolites

X Cui, X Wang, X Chang, L Bao, J Wu… - Proceedings of the …, 2023 - National Acad Sciences
Carbon-based nanomaterials (CNMs) have recently been found in humans raising a great
concern over their adverse roles in the hosts. However, our knowledge of the in vivo …